PMC:7341464 / 1921-2280
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T26 | 74-77 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T16 | 70-73 | http://purl.obolibrary.org/obo/CLO_0001079 | denotes | 148 |
| T17 | 131-133 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
| T18 | 135-140 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
| T19 | 135-140 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 0-246 | Sentence | denotes | At time of submission, 167 patients have registered for the study and 148 CML patients (median age, 57.5 years; range 26–82 years; 48% males) and 123 housemates (median age 60 years, range 24–88 years) were included, with enrolment still ongoing. |
| T16 | 247-315 | Sentence | denotes | The baseline characteristics are presented in Supplementary Table 1. |
| T17 | 316-359 | Sentence | denotes | The majority (88.4%) had taken TKI therapy. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 59 | 27-35 | Species | denotes | patients | Tax:9606 |
| 60 | 78-86 | Species | denotes | patients | Tax:9606 |
| 61 | 74-77 | Disease | denotes | CML | MESH:D015464 |